CN Patent

CN104004060B — Cyclin D蛋白抑制剂多肽及其应用

Assigned to Chongqing Medical University · Expires 2016-04-13 · 10y expired

What this patent protects

本发明涉及药物领域，具体涉及具有抑制Cyclin？D蛋白表达，治疗套细胞淋巴瘤的多肽。其序列为QAQQNMDPKAAEEEEEE是全新的序列，该多肽可体外抑制套细胞淋巴瘤细胞Mino细胞增殖，治疗套细胞淋巴瘤；在体荷瘤模型实验中，抑制Cyclin？D蛋白表达，增加了小鼠的生存率，具有潜在的新药开发价值。

USPTO Abstract

本发明涉及药物领域，具体涉及具有抑制Cyclin？D蛋白表达，治疗套细胞淋巴瘤的多肽。其序列为QAQQNMDPKAAEEEEEE是全新的序列，该多肽可体外抑制套细胞淋巴瘤细胞Mino细胞增殖，治疗套细胞淋巴瘤；在体荷瘤模型实验中，抑制Cyclin？D蛋白表达，增加了小鼠的生存率，具有潜在的新药开发价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN104004060B
Jurisdiction
CN
Classification
—
Expires
2016-04-13
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.